Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Interest & Investment Income: 2017-2025

Historic Interest & Investment Income for Akebia Therapeutics (AKBA) over the last 9 years, with Sep 2025 value amounting to -$4.7 million.

  • Akebia Therapeutics' Interest & Investment Income rose 28.72% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.2 million, marking a year-over-year decrease of 106.11%. This contributed to the annual value of -$18.2 million for FY2024, which is 201.48% down from last year.
  • As of Q3 2025, Akebia Therapeutics' Interest & Investment Income stood at -$4.7 million, which was up 30.52% from -$6.8 million recorded in Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Interest & Investment Income ranged from a high of -$1.4 million in Q3 2023 and a low of -$7.8 million during Q1 2025.
  • Its 3-year average for Interest & Investment Income is -$4.0 million, with a median of -$2.5 million in 2024.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 69.16% in 2023, then tumbled by 384.98% in 2024.
  • Akebia Therapeutics' Interest & Investment Income (Quarterly) stood at -$5.1 million in 2021, then surged by 67.81% to -$1.6 million in 2022, then climbed by 13.33% to -$1.4 million in 2023, then slumped by 384.98% to -$6.9 million in 2024, then rose by 28.72% to -$4.7 million in 2025.
  • Its Interest & Investment Income stands at -$4.7 million for Q3 2025, versus -$6.8 million for Q2 2025 and -$7.8 million for Q1 2025.